This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2.S Thomas , A Hall . What does epidemiology tell us about risk factors for herpes zoster? Lancet Infectious Diseases 2004; 4: 26–33.
3.S Langan , Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study. PLoS Medicine 2013; 10: e1001420.
4.S Buchbinder , Herpes zoster and human immunodeficiency virus infection. Journal of Infectious Diseases 1992; 166: 1153–1156.
5.D Fleming , Gender differences in the incidence of shingles. Epidemiology and Infection 2003; 132: 1–5.
6.KE Schmader , Race and stress in the incidence of herpes zoster in older adults. Journal of the American Geriatrics Society 1998; 46: 973–977.
8.S Thomas , J Wheeler , A Hall . Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet 2002; 360: 678–682.
9.M Irwin , Cellular immunity to varicella-zoster virus in patients with major depression. Journal of Infectious Diseases 1998; 178: S104–108.
10.D Weitzman , A population based study of the epidemiology of Herpes Zoster and its complications. Journal of Infection 2013; 67: 463–469.
11.M Oxman , A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. New England Journal of Medicine 2005; 352: 2271–2284.
12.K Schmader , Persistence of the efficacy of zoster vaccine in the Shingles Prevention Study and the Short-Term Persistence Substudy. Clinical Infectious Diseases 2012; 55: 1320–1328.
16.R Dworkins , Recommendations for the management of herpes zoster. Clinical Infectious Diseases 2007; 44: S1–26.
18.A Stein , Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older. Vaccine 2009; 27: 520–529.
20.B Yawn , P Wollan , J Sauver . Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they? American Journal of Epidemiology 2011; 174: 1054–1061.
21.LA Jackson , M Reynolds , R Harpaz . Hospitalizations to treat herpes zoster in older adults: causes and validated rates. Clinical Infectious Diseases 2008; 47: 754–9.
22.B Ultsch , Herpes zoster in Germany: quantifying the burden of disease. BMC Infectious Diseases 2011; 11: 173.
24.R Hays , Item response theory analyses of physical functioning items in the Medical Outcomes Study. Medical Care 2007; 45: S32–S8.
25.W Opstelten , Gender as an independent risk factor for herpes zoster: a population-based prospective study. Annals of Epidemiology 2006; 16: 692–695.
26.HF Tseng , Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. Journal of the American Medical Association 2011; 305: 160–166.
27.L Habel , The epidemiology of herpes zoster in patient with newly diagnosed cancer. Cancer Epidemiology Biomarkers and Prevention 2013; 22: 82–90.
29.S Chiappe , Herpes zoster: burden of disease in France. Vaccine 2010; 28: 7933–7938.
30.R Insinga , The incidence of herpes zoster in a United States administrative database. Journal of General Internal Medicine 2005; 20: 748–753.
31.B Ogunjimi , P Van Damme , P Beutels . Herpes zoster risk reduction through exposure to chickenpox patients: a systematic multidisciplinary review. PLoS ONE 2013; 8: e66485.
32.S Castle . Clinical relevance of age-related immune dysfunction. Clinical Infectious Diseases 2000; 31: 578–585.
34.V Morrison , Safety of zoster vaccine in elderly adults following documented herpes zoster. Journal of Infectious Diseases 2013; 208: 559–563.